Yunzhihui Technology (01037) subsidiary signed an equity transfer agreement with Shenzhen Hongzhen Enterprise Management Consulting

Zhitong Finance App News, Yunzhihui Technology (01037) issued an announcement. On May 16, 2025 (after the transaction period), the transferor Yunzhihui (Shenzhen) Hi-Tech Service Co., Ltd. (an indirect wholly-owned subsidiary of the company) and the transferee Shenzhen Hongzhen Enterprise Management Consulting Co., Ltd. (an independent third party) signed (i) an equity transfer agreement I. Based on this, the transferor agreed to sell and the transferee agreed to acquire 2.34% of the shares in the joint venture at a cost of RMB 1.672,300; and (ii) share transfer agreement II, according to which the transferor agreed Sale and transfer The people agreed to buy 16.41% of the joint venture's shares at a cost of RMB 11.727,700. As of the date of this announcement, the joint venture was 18.75% owned by the transferor.

The joint venture Shenzhen Guochuang Huikang Medical Device Technology Co., Ltd. is mainly a contract development and manufacturing organization (CDMO) for medical equipment and devices in China.

The announcement stated that due to the geopolitical risks between China and the US, and that CDMO for medical equipment and devices is not the Group's core business, the Group decided to sell its investment in the joint venture. The net proceeds will be used to develop its core business in overseas markets. The sale is expected to enhance the Group's cash flow and provide the Group with flexibility to identify and find new business opportunities.